Shimokawa, M., Tanaka, H., Yamamoto, N., Azuma, K., Hayashi, H., Toyozawa, R., . . . Tohnai, R. Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study). BMJ Publishing Group.
Chicago Style (17th ed.) CitationShimokawa, Mototsugu, et al. Phase II Study of Atezolizumab with Bevacizumab for Non-squamous Non-small Cell Lung Cancer with High PD-L1 Expression (@Be Study). BMJ Publishing Group.
MLA (9th ed.) CitationShimokawa, Mototsugu, et al. Phase II Study of Atezolizumab with Bevacizumab for Non-squamous Non-small Cell Lung Cancer with High PD-L1 Expression (@Be Study). BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.